E. V. Lyubkina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
E. V. Lyubkina has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Anton Vladimirovich Minaev
A.N. Bakulev Center for Cardiovascular Surgery of the Russian Ministry of Health
1 shared publication - G. R. Kulumbegov
A. N. Bakulev National Medical Research Center of Cardiovascular Surgery of the Ministry of Health of the Russian Federation
1 shared publication - I. I. Maslova
A.N.Bakulev National Medical Research Center of Cardiovascular Surgery of the Ministry of Health of the Russian Federation
1 shared publication - Igor A. Kovalev
A.N. Bakulev National Medical Research Center for Cardiovascular Surgery of the Russian Ministry of Health
1 shared publication - M. I. Chernenko
Bakulev Scientific Center for Cardiovascular Surgery Russian Academy of Medical Sciences (A.N. Bakulev Center)
1 shared publication - O. I. Medvedeva
Bakulev Scientific Center for Cardiovascular Surgery Russian Academy of Medical Sciences (A.N. Bakulev Center)
1 shared publication
Latest Publications
- 9 July 2026
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 41 (2)
Life-threatening arrhythmias and sudden cardiac death in congenital heart disease with systemic right ventricle (a literature review)
Adult patients with congenital heart disease (ACHD) remain a poorly studied group in terms of arrhythmological complications, while at the same time representing one of the most actively investigated cohorts with arrhythmias today. Patients with a systemic right ventricle (sRV) after atrial switch operations or with congenitally corrected transposition of the great arteries are the most vulnerable subgroups in the congenital heart disease (CHD) population; however, specific criteria for sudden cardiac death (SCD) risk stratification in these patients are still lacking. This review summarizes current knowledge on the incidence and mechanisms of SCD, including the role of arrhythmogenic substrate, myocardial fibrosis, anatomical and physiological characteristics of the sRV, and the systemic atrioventricular valve. Data from national and international registries are presented, as well as recommendations for rhythm monitoring and detection of life-threatening arrhythmias, along with the latest risk stratification scores developed specifically for patients with sRV. The need for prolonged rhythm surveillance, refinement of indications for implantable cardioverter-defibrillators in primary prevention, and further research with registry data collection to optimize management strategies is emphasized.
- 9 July 2026
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 41 (2)
Life-threatening arrhythmias and sudden cardiac death in congenital heart disease with systemic right ventricle (a literature review)
Adult patients with congenital heart disease (ACHD) remain a poorly studied group in terms of arrhythmological complications, while at the same time representing one of the most actively investigated cohorts with arrhythmias today. Patients with a systemic right ventricle (sRV) after atrial switch operations or with congenitally corrected transposition of the great arteries are the most vulnerable subgroups in the congenital heart disease (CHD) population; however, specific criteria for sudden cardiac death (SCD) risk stratification in these patients are still lacking. This review summarizes current knowledge on the incidence and mechanisms of SCD, including the role of arrhythmogenic substrate, myocardial fibrosis, anatomical and physiological characteristics of the sRV, and the systemic atrioventricular valve. Data from national and international registries are presented, as well as recommendations for rhythm monitoring and detection of life-threatening arrhythmias, along with the latest risk stratification scores developed specifically for patients with sRV. The need for prolonged rhythm surveillance, refinement of indications for implantable cardioverter-defibrillators in primary prevention, and further research with registry data collection to optimize management strategies is emphasized.
- Open Access
- 27 October 2021
- Published by Institute of Cardio Technics - INCART in Journal of Arrhythmology
- Vol. 28 (3) , 67-72
Results of radiofrequency ablation of ectopic atrial tachycardia originating from the left superior vena cava in a patient with congenital heart disease
Persistent left superior vena cava (PLSVC) is the most common anomaly of the thoracic veins (occurs in 0.2-0.6% of cases in the general population), in the vast majority of cases, PLSVC drains into the right atrium through the dilated coronary sinus and usually does not lead to significant hemodynamic disorders. The presence of PLSVC is often associated with cardiac arrhythmias; in this clinical case, we present the results of catheter ablation of arrhythmogenic foci in a 72-year-old patient with continuous-recurring ectopic tachycardia originating from the PLSVC.
- 27 October 2021
- Published by Institute of Cardio Technics - INCART in Journal of Arrhythmology
- Vol. 28 (3) , 67-72
Open AccessResults of radiofrequency ablation of ectopic atrial tachycardia originating from the left superior vena cava in a patient with congenital heart disease
Persistent left superior vena cava (PLSVC) is the most common anomaly of the thoracic veins (occurs in 0.2-0.6% of cases in the general population), in the vast majority of cases, PLSVC drains into the right atrium through the dilated coronary sinus and usually does not lead to significant hemodynamic disorders. The presence of PLSVC is often associated with cardiac arrhythmias; in this clinical case, we present the results of catheter ablation of arrhythmogenic foci in a 72-year-old patient with continuous-recurring ectopic tachycardia originating from the PLSVC.